These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 28405825)

  • 1. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
    van der Goes MC; Jacobs JW; Jurgens MS; Bakker MF; van der Veen MJ; van der Werf JH; Welsing PM; Bijlsma JW
    Osteoporos Int; 2013 Apr; 24(4):1429-36. PubMed ID: 23011680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs.
    Tokumoto H; Tominaga H; Arishima Y; Jokoji G; Akimoto M; Ohtsubo H; Taketomi E; Sunahara N; Nagano S; Ishidou Y; Komiya S; Setoguchi T
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29463015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T
    Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C; Karlsson M; Akesson K; Jacobsson L
    Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials.
    Siu S; Haraoui B; Bissonnette R; Bessette L; Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Kraft J; Lynde C; Gulliver W; Keeling S; Dutz J; Pope JE
    Arthritis Care Res (Hoboken); 2015 May; 67(6):754-64. PubMed ID: 25418272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
    Ma CC; Xu SQ; Gong X; Wu Y; Qi S; Liu W; Xu JH
    Arch Osteoporos; 2017 Dec; 12(1):33. PubMed ID: 28374332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
    Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study.
    Lee JS; Lim DH; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Rheumatol Int; 2020 Mar; 40(3):481-487. PubMed ID: 31414225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids.
    Matsuno H
    Drugs R D; 2016 Dec; 16(4):347-353. PubMed ID: 27766589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
    Jensen TW; Hansen MS; Hørslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Pødenphant J; Stengaard-Petersen K; Junker P; Østergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML;
    Ann Rheum Dis; 2014 Jun; 73(6):1123-9. PubMed ID: 23661492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
    Güler-Yüksel M; Bijsterbosch J; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Hulsmans HM; de Beus WM; Han KH; Breedveld FC; Dijkmans BA; Allaart CF; Lems WF
    Ann Rheum Dis; 2008 Jun; 67(6):823-8. PubMed ID: 17644545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
    Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
    Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis Self-Assessment Tool As a Screening Tool for Predicting Osteoporosis in Elderly Chinese Patients With Established Rheumatoid Arthritis.
    Tong H; Zong HX; Xu SQ; Wang XR; Gong X; Xu JH; Cheng M
    J Clin Densitom; 2019; 22(3):321-328. PubMed ID: 30205984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of body composition and bone mineral density in women with rheumatoid arthritis].
    Silva RG; Pippa MG; Zerbin CA
    Rev Assoc Med Bras (1992); 2007; 53(2):135-41. PubMed ID: 17568917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls.
    Gilboe IM; Kvien TK; Haugeberg G; Husby G
    Ann Rheum Dis; 2000 Feb; 59(2):110-5. PubMed ID: 10666165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylaxis and treatment of osteoporosis in patients with rheumatoid arthritis (ORA study)].
    Heberlein I; Demary W; Bloching H; Braun J; Buttgereit F; Dreher R; Kuhn C; Lange U; Pollähne W; Zink A; Zeidler H; Häntzschel H; Raspe H
    Z Rheumatol; 2011 Nov; 70(9):793-8, 800-2. PubMed ID: 21956827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.
    Nakamura Y; Suzuki T; Kato H
    Arch Osteoporos; 2017 Sep; 12(1):80. PubMed ID: 28936606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment].
    Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.